HK2 and hepatocellular carcinoma: Indeed, resveratrol suppressed EGFR, Akt, and ERK1/2 activation, which led to inhibition of HK2-mediating glycolysis in NSCLC [180]; down-regulated HK2 in hepatocellular carcinoma both in vitro and in vivo [181].